Epoch Investment Partners’s Takeda Pharmaceutical TAK Stock Holding History

Epoch Investment Partners’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,462	Closed	-$221K	–	362
2021 Q3	$221K	Sell	13,462 -23,587	-64%	-$396K	﹤0.01%	346
2021 Q2	$624K	Sell	37,049 -71,508	-66%	-$1.22M	﹤0.01%	312
2021 Q1	$1.98M	Sell	108,557 -930	-0.8%	-$16.7K	0.01%	300
2020 Q4	$1.99M	Buy	109,487 +8,147	+8%	+$143K	0.01%	300
2020 Q3	$1.81M	Sell	101,340 -1,427	-1%	-$26K	0.01%	275
2020 Q2	$1.84M	Sell	102,767 -11,070	-10%	-$199K	0.01%	258
2020 Q1	$1.73M	Sell	113,837 -93,718	-45%	-$1.7M	0.01%	246
2019 Q4	$4.09M	Buy	207,555 +2,887	+1%	+$55.2K	0.02%	251
2019 Q3	$3.52M	Buy	204,668 +12,669	+7%	+$219K	0.02%	243
2019 Q2	$3.4M	Buy	191,999 +49,213	+34%	+$896K	0.02%	248
2019 Q1	$2.91M	Buy	+142,786	New	+$2.87M	0.01%	276

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Epoch Investment Partners's TAK Position: Q4 2021 in Review

Epoch Investment Partners sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 13,462 shares — an estimated $221K sold.

Epoch Investment Partners first reported a position in TAK in Q1 2019 and held it in 11 quarters. The position peaked at $4.09M in Q4 2019. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

Epoch Investment Partners reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Epoch Investment Partners sold 13,462 Takeda Pharmaceutical shares in Q4 2021, an estimated $221K.
Epoch Investment Partners first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 11 quarters.
Epoch Investment Partners's Takeda Pharmaceutical position peaked at $4.09M in Q4 2019.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Epoch Investment Partners's 13F filing for Q4 2021, filed 11 Feb 2022.